Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006232
Status:
COMPLETED
Last Update Posted:
2013-05-15
First Post:
2000-09-11
Brief Title:
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma
Sponsor:
West of Scotland Lymphoma Group
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
WSLG-H31
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
West of Scotland Lymphoma Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None